These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 37368228)

  • 21. Noninvasive prediction of residual disease for advanced high-grade serous ovarian carcinoma by MRI-based radiomic-clinical nomogram.
    Li H; Zhang R; Li R; Xia W; Chen X; Zhang J; Cai S; Li Y; Zhao S; Qiang J; Peng W; Gu Y; Gao X
    Eur Radiol; 2021 Oct; 31(10):7855-7864. PubMed ID: 33864139
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MR image-based radiomics to differentiate type Ι and type ΙΙ epithelial ovarian cancers.
    Jian J; Li Y; Pickhardt PJ; Xia W; He Z; Zhang R; Zhao S; Zhao X; Cai S; Zhang J; Zhang G; Jiang J; Zhang Y; Wang K; Lin G; Feng F; Wu X; Gao X; Qiang J
    Eur Radiol; 2021 Jan; 31(1):403-410. PubMed ID: 32743768
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CT radiomics may predict the grade of pancreatic neuroendocrine tumors: a multicenter study.
    Gu D; Hu Y; Ding H; Wei J; Chen K; Liu H; Zeng M; Tian J
    Eur Radiol; 2019 Dec; 29(12):6880-6890. PubMed ID: 31227882
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic value of integrated ¹⁸F-fluoro-2-deoxyglucose positron emission tomography/computed tomography in recurrent epithelial ovarian cancer: accuracy of patient selection for secondary cytoreduction in 134 patients.
    Lee YJ; Kim YM; Jung PS; Lee JJ; Kim JK; Kim YT; Nam JH
    J Gynecol Oncol; 2018 May; 29(3):e36. PubMed ID: 29400023
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incorporating SULF1 polymorphisms in a pretreatment CT-based radiomic model for predicting platinum resistance in ovarian cancer treatment.
    Yi X; Liu Y; Zhou B; Xiang W; Deng A; Fu Y; Zhao Y; Ouyang Q; Liu Y; Sun Z; Zhang K; Li X; Zeng F; Zhou H; Chen BT
    Biomed Pharmacother; 2021 Jan; 133():111013. PubMed ID: 33227705
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radiomic signature of the FOWARC trial predicts pathological response to neoadjuvant treatment in rectal cancer.
    Zhuang Z; Liu Z; Li J; Wang X; Xie P; Xiong F; Hu J; Meng X; Huang M; Deng Y; Lan P; Yu H; Luo Y
    J Transl Med; 2021 Jun; 19(1):256. PubMed ID: 34112180
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Application of enhanced computed tomography-based radiomics nomogram analysis to differentiate metastatic ovarian tumors from epithelial ovarian tumors.
    Zhang A; Hu Q; Ma Z; Song J; Chen T
    J Xray Sci Technol; 2022; 30(6):1185-1199. PubMed ID: 36189526
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radiomic signature as a diagnostic factor for histologic subtype classification of non-small cell lung cancer.
    Zhu X; Dong D; Chen Z; Fang M; Zhang L; Song J; Yu D; Zang Y; Liu Z; Shi J; Tian J
    Eur Radiol; 2018 Jul; 28(7):2772-2778. PubMed ID: 29450713
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identifying pathological subtypes of non-small-cell lung cancer by using the radiomic features of
    Sha X; Gong G; Qiu Q; Duan J; Li D; Yin Y
    Transl Cancer Res; 2019 Sep; 8(5):1741-1749. PubMed ID: 35116924
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radiomic model to predict the expression of PD-1 and overall survival of patients with ovarian cancer.
    Gao L; Jiang W; Yue Q; Ye R; Li Y; Hong J; Zhang M
    Int Immunopharmacol; 2022 Dec; 113(Pt A):109335. PubMed ID: 36279669
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pretreatment
    Dissaux G; Visvikis D; Da-Ano R; Pradier O; Chajon E; Barillot I; Duvergé L; Masson I; Abgral R; Santiago Ribeiro MJ; Devillers A; Pallardy A; Fleury V; Mahé MA; De Crevoisier R; Hatt M; Schick U
    J Nucl Med; 2020 Jun; 61(6):814-820. PubMed ID: 31732678
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intratumoral and peritumoral radiomics analysis for preoperative Lauren classification in gastric cancer.
    Wang XX; Ding Y; Wang SW; Dong D; Li HL; Chen J; Hu H; Lu C; Tian J; Shan XH
    Cancer Imaging; 2020 Nov; 20(1):83. PubMed ID: 33228815
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ultrasound-based radiomics for predicting different pathological subtypes of epithelial ovarian cancer before surgery.
    Tang ZP; Ma Z; He Y; Liu RC; Jin BB; Wen DY; Wen R; Yin HH; Qiu CC; Gao RZ; Ma Y; Yang H
    BMC Med Imaging; 2022 Aug; 22(1):147. PubMed ID: 35996097
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identifying high-risk colon cancer on CT an a radiomics signature improve radiologist's performance for T staging?
    Hong EK; Bodalal Z; Landolfi F; Bogveradze N; Bos P; Park SJ; Lee JM; Beets-Tan R
    Abdom Radiol (NY); 2022 Aug; 47(8):2739-2746. PubMed ID: 35661244
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A CT-based radiomics nomogram for differentiation of renal angiomyolipoma without visible fat from homogeneous clear cell renal cell carcinoma.
    Nie P; Yang G; Wang Z; Yan L; Miao W; Hao D; Wu J; Zhao Y; Gong A; Cui J; Jia Y; Niu H
    Eur Radiol; 2020 Feb; 30(2):1274-1284. PubMed ID: 31506816
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparative study to evaluate CT-based semantic and radiomic features in preoperative diagnosis of invasive pulmonary adenocarcinomas manifesting as subsolid nodules.
    Wu YJ; Liu YC; Liao CY; Tang EK; Wu FZ
    Sci Rep; 2021 Jan; 11(1):66. PubMed ID: 33462251
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preoperative CT Radiomics Predicting the SSIGN Risk Groups in Patients With Clear Cell Renal Cell Carcinoma: Development and Multicenter Validation.
    Jiang Y; Li W; Huang C; Tian C; Chen Q; Zeng X; Cao Y; Chen Y; Yang Y; Liu H; Bo Y; Luo C; Li Y; Zhang T; Wang R
    Front Oncol; 2020; 10():909. PubMed ID: 32850304
    [No Abstract]   [Full Text] [Related]  

  • 38. Machine-learning-based contrast-enhanced computed tomography radiomic analysis for categorization of ovarian tumors.
    Li J; Zhang T; Ma J; Zhang N; Zhang Z; Ye Z
    Front Oncol; 2022; 12():934735. PubMed ID: 36016613
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Computed Tomography-Based Radiomics Model to Predict Central Cervical Lymph Node Metastases in Papillary Thyroid Carcinoma: A Multicenter Study.
    Li J; Wu X; Mao N; Zheng G; Zhang H; Mou Y; Jia C; Mi J; Song X
    Front Endocrinol (Lausanne); 2021; 12():741698. PubMed ID: 34745008
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Magnetic resonance imaging radiomics predicts preoperative axillary lymph node metastasis to support surgical decisions and is associated with tumor microenvironment in invasive breast cancer: A machine learning, multicenter study.
    Yu Y; He Z; Ouyang J; Tan Y; Chen Y; Gu Y; Mao L; Ren W; Wang J; Lin L; Wu Z; Liu J; Ou Q; Hu Q; Li A; Chen K; Li C; Lu N; Li X; Su F; Liu Q; Xie C; Yao H
    EBioMedicine; 2021 Jul; 69():103460. PubMed ID: 34233259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.